Solara Active Pharma Sciences Limited

What to Watch

• EarningsThe company reported a net loss in FY26 (consolidated) after a profit the prior year. Watch the return to profitability and its drivers.
• RevenueRevenue contracted at a -1.8% CAGR over the 3-year period (FY23–FY26). Watch for revenue stabilization in upcoming quarters.
• ValuationThe shares trade at 83× trailing earnings; the multiple assumes sustained high growth and is sensitive to any slowdown.